The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. In this multicenter, ...

Because type 1 diabetes can be very difficult to effectively manage in children and adolescents, these study investigators compared outcomes between a hybrid closed-loop algorithm add-on and usual ...

Currently, one closed-loop system, the Medtronic MiniMed 670G, is in commercial use in the United States, but randomized trials are needed to assess its efficacy and safety. 8 Such a system, which ...

Representation of the closed-loop device, the Control-IQ artificial pancreas system, which uses a control algorithm developed at the University of Virginia. (Courtesy: Tandem Diabetes Care) The burden ...

Closed-loop control systems of insulin delivery may improve glycemic outcomes in young children with type 1 diabetes. The efficacy and safety of initiating a closed-loop system virtually are unclear.